Carregant...
Sorafenib Combined with Cryoablation to Treat Unresectable Hepatocellular Carcinoma
OBJECTIVE: To evaluate the efficacy and tolerability of sorafenib combined with cryoablation in treating unresectable hepatocellular carcinoma (HCC). METHODS: Patients with unresectable advanced HCC received cryoablation and sorafenib at a dose of 400 mg twice daily in 4-week cycles on the same day...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer-Verlag Berlin Heidelberg
2011
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3587556/ https://ncbi.nlm.nih.gov/pubmed/23467380 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11670-011-0188-y |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|